These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34671559)

  • 1. High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer.
    Yang R; Ma M; Yu S; Li X; Zhang J; Wu S
    Front Oncol; 2021; 11():742017. PubMed ID: 34671559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
    Lo PH; Tanikawa C; Katagiri T; Nakamura Y; Matsuda K
    Oncol Rep; 2015 Jan; 33(1):267-73. PubMed ID: 25370079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance.
    Liu T; Ma Y; Wang Z; Zhang W; Yang X
    Cancer Manag Res; 2020; 12():303-311. PubMed ID: 32021444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
    Wang JM; Ju BH; Pan CJ; Gu Y; Li MQ; Sun L; Xu YY; Yin LR
    Am J Transl Res; 2017; 9(8):3541-3557. PubMed ID: 28861147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.
    Xu J; Wang H; Wang H; Chen Q; Zhang L; Song C; Zhou Q; Hong Y
    Hereditas; 2019; 156():11. PubMed ID: 31007650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family with sequence similarity 83 member A promotes tumor cell proliferation and metastasis and predicts poor prognosis in cervical cancer.
    Liu T; Chen J; Du Q; Liu J; Chen M; Ooi S; Huang J; Wang W; Yao S
    Pathol Res Pract; 2021 Jun; 222():153450. PubMed ID: 33962175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer.
    Xing F; Song Z; Cheng Z
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36082822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling.
    Huang LQ; Zheng B; He Y
    Open Life Sci; 2019 Jan; 14():528-536. PubMed ID: 33817189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-κB-Snail pathway.
    Zhong M; Liu Z; Wu K; Hong Z; Zhang Y; Qu J; Zhu C; Ou Z; Zeng T
    Int J Clin Exp Pathol; 2020; 13(3):607-615. PubMed ID: 32269702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAF-1/p150 promotes cell proliferation, migration, invasion and predicts a poor prognosis in patients with cervical cancer.
    Yang S; Long Q; Chen M; Liu X; Zhou H
    Oncol Lett; 2020 Sep; 20(3):2338-2346. PubMed ID: 32782551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
    Zhang X; Li F; Zhu PL
    Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPI1-related protein inhibits cervical cancer cell progression and prevents macrophage cell migration.
    Jin J; Du X; Zhou L; Yao D; Zou Q
    J Obstet Gynaecol Res; 2022 Sep; 48(9):2419-2430. PubMed ID: 35770729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of METTL14 inhibits the growth and invasion of cervical cancer.
    Geng F; Fan MJ; Li J; Liang SM; Li CY; Li N
    Transl Cancer Res; 2019 Oct; 8(6):2307-2315. PubMed ID: 35116983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
    He JH; Chen JG; Zhang B; Chen J; You KL; Hu JM; Xu JW; Chen L
    Technol Cancer Res Treat; 2020; 19():1533033820936773. PubMed ID: 32618228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.
    Jiang L; Wang X
    Bioengineered; 2022 Feb; 13(2):3323-3332. PubMed ID: 35048795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.
    Xu J; Zhang W
    Cancer Cell Int; 2021 Oct; 21(1):521. PubMed ID: 34627255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.